These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 1244226

  • 1. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake, and the renin-angiotensin system in healthy young women.
    Hollenberg NK, Williams GH, Burger B, Chenitz W, Hoosmand I, Adams DF.
    Circ Res; 1976 Jan; 38(1):35-40. PubMed ID: 1244226
    [Abstract] [Full Text] [Related]

  • 2. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH, Kramer NJ, Grim CE, Petersen LP.
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced hypertension: pathogenesis and management.
    Stokes GS.
    Drugs; 1976 Jan; 12(3):222-30. PubMed ID: 185040
    [Abstract] [Full Text] [Related]

  • 4. Oral contraceptives--induced hypertension--nine years later.
    Laragh JH.
    Am J Obstet Gynecol; 1976 Sep 01; 126(1):141-7. PubMed ID: 961741
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr 01; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives.
    McAreavey D, Cumming AM, Boddy K, Brown JJ, Fraser R, Leckie BJ, Lever AF, Morton JJ, Robertson JI, Williams ED.
    Clin Endocrinol (Oxf); 1983 Feb 01; 18(2):111-8. PubMed ID: 6851195
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec 01; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 9. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
    Saruta T, Nakamura R, Nagahama S, Suzuki H, Kondo K.
    Gynecol Obstet Invest; 1981 Apr 01; 12(1):11-20. PubMed ID: 7019015
    [Abstract] [Full Text] [Related]

  • 10. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun 01; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 11. Oral contraceptives and ascorbic acid.
    Rivers JM.
    Am J Clin Nutr; 1975 May 01; 28(5):550-4. PubMed ID: 1093379
    [Abstract] [Full Text] [Related]

  • 12. Oestrogens and hypertension.
    Roberts JM.
    Clin Endocrinol Metab; 1981 Nov 01; 10(3):489-512. PubMed ID: 7047019
    [Abstract] [Full Text] [Related]

  • 13. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M, Saruta T, Nakamura R, Saito I, Kondo K, Kato E.
    Gynecol Obstet Invest; 1979 Nov 01; 10(5):246-53. PubMed ID: 395034
    [Abstract] [Full Text] [Related]

  • 14. Effects of estrogens and progestogens on lipid metabolism.
    Oster P, Arab L, Kohlmeier M, Mordasini R, Schellenberg B, Schlierf G.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):773-5. PubMed ID: 7065057
    [Abstract] [Full Text] [Related]

  • 15. [Changes of the renin-angiotensin-aldosterone system under contraceptive steroids. Contribution to the etiology of hypertension under hormonal contraceptives].
    Kaulhausen H, Klingsiek L, Breuer H.
    Fortschr Med; 1976 Nov 18; 94(33):1925-30. PubMed ID: 186375
    [Abstract] [Full Text] [Related]

  • 16. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J, Rabinowe S, Hollenberg NK, Williams GH.
    J Clin Invest; 1985 Apr 18; 75(4):1285-90. PubMed ID: 2985655
    [Abstract] [Full Text] [Related]

  • 17. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH, Steunkel C, Schalekamp MP, Visser W, Huisveld IH, Schalekamp MA.
    J Clin Endocrinol Metab; 1986 Oct 18; 63(4):1008-15. PubMed ID: 3528208
    [Abstract] [Full Text] [Related]

  • 18. Renal hemodynamic and tubular responses to salt in women using oral contraceptives.
    Pechère-Bertschi A, Maillard M, Stalder H, Bischof P, Fathi M, Brunner HR, Burnier M.
    Kidney Int; 2003 Oct 18; 64(4):1374-80. PubMed ID: 12969156
    [Abstract] [Full Text] [Related]

  • 19. Effect of antihypertensive drugs on the renin-angiotensin system.
    Johnston CI.
    Drugs; 1976 Oct 18; 12(4):274-91. PubMed ID: 786609
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral contraceptives on the renin angiotensin system and renal function.
    Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA.
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar 18; 280(3):R807-13. PubMed ID: 11171661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.